Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05400395` - Clinical Trial for GNX80 in Intermittent Claudication	Phase 4
Active, not recruiting	`NCT02341716` - Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication	N/A
Completed	`NCT02041169` - Lower Extremity Peripheral Arterial Disease and Exercise Ischemia	N/A
Completed	`NCT00822172` - Evaluation of Cilostazol in Combination With L-Carnitine	Phase 4
Recruiting	`NCT00538408` - Whole Body Magnetic Resonance Angiography in Ischemic Patients	N/A
Completed	`NCT00618670` - Home-based vs. Supervised Exercise for People With Claudication	N/A
Completed	`NCT00388128` - Caffeine and Intermittent Claudication	Phase 3
Recruiting	`NCT00146666` - Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)	Phase 2
Completed	`NCT00134277` - Trial Comparing Different Medical Devices for Infragenual Dilatation	N/A
Completed	`NCT01256775` - Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)	Phase 2
Completed	`NCT00029991` - Extract of Ginkgo Biloba (EGB 761) and Vascular Function	Phase 1/Phase 2
Recruiting	`NCT06299956` - Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark	N/A
Not yet recruiting	`NCT05335161` - A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease	Phase 1
Completed	`NCT04390282` - Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication	N/A
Completed	`NCT03271710` - Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System	N/A
Completed	`NCT02380794` - Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule	Phase 2
Active, not recruiting	`NCT02276937` - Randomized Phase IIb Trial of DVC1-0101	Phase 2
Completed	`NCT02097082` - Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System	N/A
Recruiting	`NCT00539266` - Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia	Phase 2/Phase 3
Completed	`NCT00071266` - The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC	Phase 3

NCT number	NCT00602407
Study type	Interventional
Source	West-Ward Pharmaceutical
Contact
Status	Completed
Phase	N/A
Start date	February 2004
Completion date	March 2004

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms